论文部分内容阅读
目的探讨CIK细胞维持治疗40例晚期肺癌患者的免疫状况以及生活质量影响。方法选取2014年11月至2015年12月在我院接受治疗的40例晚期肺癌患者,按照随机数表法将40例患者分为观察组和对照组各20例,观察组患者采用CIK细胞维持治疗,对照组采用单纯化疗治疗,比较两组患者治疗效果。结果化疗后,观察组患者的免疫功能以及生活质量均高于对照组,两组患者进行比较,差异具有统计学意义(P<0.05),观察组患者临床治疗效果良好。结论 CIK细胞维持治疗40例晚期肺癌患者,可以改善患者的免疫状况,提高患者的生活质量,临床疗效好,值得推广。
Objective To investigate the immune status and quality of life of 40 patients with advanced lung cancer treated with CIK cells. Methods Forty patients with advanced lung cancer treated in our hospital from November 2014 to December 2015 were selected and divided into observation group (20 cases) and control group (20 cases) according to the random number table method. Patients in the observation group were maintained with CIK cells Treatment, the control group with chemotherapy alone, the treatment effect of two groups were compared. Results After chemotherapy, the immunological function and quality of life in the observation group were higher than those in the control group. There was significant difference between the two groups (P <0.05). The clinical efficacy of the observation group was good. Conclusion CIK cell maintenance treatment of 40 cases of advanced lung cancer patients can improve the patient’s immune status and improve the quality of life of patients with good clinical efficacy, it is worth promoting.